Low-dose Interferon-alfa Does Not Improve Outcomes of Patients with Renal Cell ... - Cancer Consultants PDF Print
Cancer ConsultantsUpfront, randomized, phase 2 trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma: clinical and

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.